Pandion Therapeutics, Inc.

Artificial intelligence and machine learning-powered technology platforms have increased in number and investor interest based on the potential for AI/ML to shorten the discovery stage of research and

Merck & Co is in advanced discussions with Seagen about a possible takeover bid, according to the Wall Street Journal , but sources close to talks have said a deal is not yet imminent. The newspap

Rising Leaders Home Immunology is not the first therapeutic area that springs to mind when one thinks of Merck & Co., Inc. but the pharma major’s immunology clinical research head, Aileen Pangan, i

Rising Leaders Home Murat Tunaboylu, co-founder and CEO of artificial intelligence-powered drug discovery firm Antiverse Ltd. , did not start out in life sciences. Instead, he began his career as a